Hypoglycemic Effect of Nobiletin via Gut Microbiota‐Metabolism Axis on Hyperglycemic Mice
Molecular Nutrition & Food Research · 2023
DOI: 10.1002/mnfr.202200289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Nutrition & Food Research, 2023. Verfasst von Xiaoshan Liao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical…. Hauptthemen laut MEDLINE: Hypoglycemic Agents, Gastrointestinal Microbiome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Key R&D Program, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
Scope Prediabetes and diabetes are major public health problems worldwide without specific cure currently. Gut microbes have been recognized as one of the vital therapeutic targets for diabetes. The exploration that nobiletin (NOB) whether affects gut microbes provides a scientific basis for its application. Methods and results A hyperglycemia animal model is established using high‐fat‐fed ApoE −/− mice. After 24 weeks of NOB intervention, the level of fasting blood glucose (FBG), glucose tolerance, insulin resistance, and glycosylated serum protein (GSP) are measured. Pancreas integrity is observed by hematoxylin‐eosin (HE) staining and transmission electron microscopy. 16s RNA sequencing and untargeted metabolomics are to determine the changes of intestinal microbial composition and metabolic pathways. The levels of FBG and GSP in hyperglycemic mice are effectively reduced. The secretory function of pancreas is improved. Meanwhile, NOB treatment restored the gut microbial composition and affected metabolic function. Furthermore, NOB treatment regulates the metabolic disorder mainly through lipid metabolism, amino acid metabolism, and Secondary bile acid metabolism, etc. In addition, it is possibly existed mutual promotion between microbe and metabolites. Conclusion NOB probably plays a vital role in the hypoglycemic effect and pancreatic islets protection by improving microbiota composition and gut metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, Guangdong, 510515, China.
- School of Biological Science, University of California Irvine, Irvine, CA, 92697, USA.
ORCID-Profile: Wenzhen Liao
Förderung
- National Natural Science Foundation of China
- Guangdong Key R&D Program
- Guangdong Basic and Applied Basic Research Foundation
- Regular Institutions of Higher Learning Characteristic Innovation Projects of Guangdong Province
Zitieren
APA
Liao, X., Zou, J., Wu, M., Deng, Y., Shi, J., Hao, Y., Deng, H., & Liao, W. (2023). Hypoglycemic Effect of Nobiletin via Gut Microbiota‐Metabolism Axis on Hyperglycemic Mice. Molecular Nutrition & Food Research. https://doi.org/10.1002/mnfr.202200289
Vancouver
Liao X, Zou J, Wu M, Deng Y, Shi J, Hao Y, et al. Hypoglycemic Effect of Nobiletin via Gut Microbiota‐Metabolism Axis on Hyperglycemic Mice. Molecular Nutrition & Food Research. 2023. doi:10.1002/mnfr.202200289
BibTeX
@article{Liao2023,
author = {Liao, Xiaoshan and Zou, Jiaxuan and Wu, Mengting and Deng, Yudi and Shi, Jinwei and Hao, Yuting and Deng, Hong and Liao, Wenzhen},
title = {Hypoglycemic Effect of Nobiletin via Gut Microbiota‐Metabolism Axis on Hyperglycemic Mice},
journal = {Molecular Nutrition & Food Research},
year = {2023},
doi = {10.1002/mnfr.202200289}
}
EUVIMED